Literature DB >> 2901414

Glucagon gene expression in vertebrate brain.

D J Drucker1, S Asa.   

Abstract

An increasing number of regulatory peptide genes are known to be transcribed in neuroendocrine cells of the intestine and neurons of the central and peripheral nervous system. The discovery of the expression of peptide hormone genes in the nervous system has led to the suggestion that these peptides may function as neurotransmitters, neuromodulators, and releasing or inhibiting factors in different regions of the brain. Glucagon and the glucagon-like peptides are derived from proglucagon in the pancreatic islets and intestine. A role for these peptides in the central nervous system has been proposed, but evidence for the biosynthesis of proglucagon in brain has been lacking. We now report that the glucagon gene is expressed in the brainstem and hypothalamus and that a glucagon mRNA transcript identical to that produced in pancreas and intestine gives rise to proglucagon-related peptides in the brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901414

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Gut adaptation and the glucagon-like peptides.

Authors:  D J Drucker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

2.  Direct regulation of the proglucagon gene by insulin, leptin, and cAMP in embryonic versus adult hypothalamic neurons.

Authors:  Prasad S Dalvi; Frederick D Erbiceanu; David M Irwin; Denise D Belsham
Journal:  Mol Endocrinol       Date:  2012-06-05

Review 3.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 4.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

5.  POU domain transcription factor brain 4 confers pancreatic alpha-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element.

Authors:  M A Hussain; J Lee; C P Miller; J F Habener
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

Review 6.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

Review 7.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

8.  The serendipitous origin of chordate secretin peptide family members.

Authors:  João C R Cardoso; Florbela A Vieira; Ana S Gomes; Deborah M Power
Journal:  BMC Evol Biol       Date:  2010-05-06       Impact factor: 3.260

9.  Effect of catch-up growth after food restriction on the entero-insular axis in rats.

Authors:  Lu-Lu Chen; Wei-Hong Yang; Juan Zheng; Xiang Hu; Wen Kong; Hao-Hao Zhang
Journal:  Nutr Metab (Lond)       Date:  2010-05-26       Impact factor: 4.169

10.  Alterations in ZENK and glucagon RNA transcript expression during increased ocular growth in chickens.

Authors:  Regan Ashby; Peter Kozulin; Pam L Megaw; Ian G Morgan
Journal:  Mol Vis       Date:  2010-04-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.